ArticleDiscover oncology2022

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A.

Nichelle C Whitlock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.